Page last updated: 2024-10-24

cerebral cortex neuron differentiation

Definition

Target type: biologicalprocess

The process in which a relatively unspecialized cell acquires specialized features of a neuron residing in the cerebral cortex. [GO_REF:0000021, GOC:cls, GOC:dgh, GOC:dph, GOC:jid]

Cerebral cortex neuron differentiation is a complex and tightly regulated process that involves a series of molecular events and cellular transformations. It begins with the generation of neural progenitors in the ventricular zone of the developing brain. These progenitors undergo a series of divisions, giving rise to different types of neurons and glia. The process of neuronal differentiation is characterized by the expression of specific genes that control the development of neuronal morphology, neurotransmitter identity, and functional properties. It involves:

1. **Specification:** Neural progenitors receive signals from the surrounding environment, including secreted factors and cell-cell interactions, which determine their fate and direct them to become specific types of neurons. This process is regulated by a complex interplay of transcription factors, signaling pathways, and epigenetic modifications.

2. **Cell Cycle Exit and Migration:** Progenitors exit the cell cycle and migrate from the ventricular zone to their final destination in the cortical layers. This migration is guided by radial glial fibers and is influenced by various chemoattractant and chemorepellent molecules.

3. **Morphological Differentiation:** As neurons migrate, they begin to differentiate, developing their characteristic shape, dendrites, and axons. This involves the dynamic regulation of cytoskeletal proteins, including microtubules and actin filaments, as well as the formation of specialized cellular compartments.

4. **Synaptic Formation:** Neurons form synapses, specialized junctions where they communicate with each other. Synapse formation is a complex process that involves the precise alignment of presynaptic and postsynaptic components, the assembly of neurotransmitter receptors, and the regulation of synaptic plasticity.

5. **Functional Maturation:** During functional maturation, neurons refine their synaptic connections, integrate into neural circuits, and acquire their specific functional properties. This includes the development of specific neurotransmitter systems, the formation of neuronal networks, and the integration of sensory and motor input.

6. **Myelination:** In the later stages of development, axons of cortical neurons are myelinated by oligodendrocytes, which increases the speed of neuronal signaling and contributes to the mature function of the cerebral cortex.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Nuclear receptor subfamily 2 group E member 1A nuclear receptor subfamily 2 group E member 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y466]Homo sapiens (human)
Hypoxanthine-guanine phosphoribosyltransferaseA hypoxanthine-guanine phosphoribosyltransferase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P00492]Homo sapiens (human)

Compounds (17)

CompoundDefinitionClassesRoles
propafenonepropafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
aromatic ketone;
secondary alcohol;
secondary amino compound
anti-arrhythmia drug
propranololpropranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
naphthalenes;
propanolamine;
secondary amine
anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
chrysenechrysene : An ortho-fused polycyclic arene found commonly in the coal tar.

chrysene: structure in Merck Index, 9th ed, #2252
ortho-fused polycyclic areneplant metabolite
6-chrysenamine6-chrysenamine: may cause splenic atrophy and leukopenia; minor descriptor (76-84); on-line & Index Medicus search PHENANTHRENES (76-84)carbopolycyclic compound
dexpropranololpropranolol
6-nitrochrysene6-nitrochrysene: RN given refers to cpd with locant for nitro group in position 6carbopolycyclic compound
tryptolinetryptoline: neurotoxic factor that may be involved in development of Parkinson's disease; enzymatic prep from human brain converts tryptamine to tryptoline; RN given refers to parent cpd; structurebeta-carbolines
tadalafilbenzodioxoles;
pyrazinopyridoindole
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
n-desisopropylpropranololN-desisopropylpropranolol: RN given refers to parent cpd
mercaptopurinemercaptopurine : A member of the class of purines that is 6,7-dihydro-1H-purine carrying a thione group at position 6. An adenine analogue, it is used in the treatment of acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), Crohn's disease, and ulcerative colitis.

Mercaptopurine: An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.

purine-6-thiol : A thiol that is the tautomer of mercaptopurine.
aryl thiol;
purines;
thiocarbonyl compound
anticoronaviral agent;
antimetabolite;
antineoplastic agent
thioguanine anhydrousThioguanine: An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.

tioguanine : A 2-aminopurine that is the 6-thiono derivative of 2-amino-1,9-dihydro-6H-purine. Incorporates into DNA and inhibits synthesis. Used in the treatment of leukaemia.
2-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
guanosine monophosphateguanosine 5'-monophosphate : A purine ribonucleoside 5'-monophosphate having guanine as the nucleobase.

Guanosine Monophosphate: A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature.
guanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate
biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite
guanine2-aminopurines;
oxopurine;
purine nucleobase
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
hypoxanthinenucleobase analogue;
oxopurine;
purine nucleobase
fundamental metabolite
inosinic acidInosine Monophosphate: Inosine 5'-Monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety.inosine phosphate;
purine ribonucleoside 5'-monophosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
allopurinolallopurinol : A bicyclic structure comprising a pyrazole ring fused to a hydroxy-substituted pyrimidine ring.

Allopurinol: A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.
nucleobase analogue;
organic heterobicyclic compound
antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
azaguanine8-azaguanine : A triazolopyrimidine that consists of 3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidine bearing amino and oxo substituents at positions 5 and 7 respectively.

Azaguanine: One of the early purine analogs showing antineoplastic activity. It functions as an antimetabolite and is easily incorporated into ribonucleic acids.
nucleobase analogue;
triazolopyrimidines
antimetabolite;
antineoplastic agent;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor